Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Shanghai Pharma Spending to Build Drug Distribution Business

publication date: Jul 13, 2011
Shanghai Pharmaceutical Holding plans to make a 2 billion RMB ($310 million) capital expenditure that will, among other things, solidify its drug distribution business in North China. The company will put 1 billion RMB ($155 million) of capital in its distribution subsidiary to bulk up its sales network. Another $80 million will go to establish a sales unit in North China, and it will spend 500 million RMB ($75 million) in an information technology venture. More details....

Stock Symbol: (SHA: 601607)     Share this with colleagues:  

 


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital